Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThigh vs stomach for Mounjaro: what the evidence and practice actually tell us
You're holding the pen and wondering if you chose the wrong spot last week
Most people starting Mounjaro default to the stomach because it feels obvious — belly fat, weight medicine, obvious connection. It's a logical guess, but also a misconception worth clearing up gently: the injection site has nothing to do with where fat is reduced. Tirzepatide acts systemically once it's absorbed into the bloodstream; it doesn't target fat at the site. The abdomen simply happens to be the site many people try first because it's easy to reach and has a generous pinch of subcutaneous tissue.
The upper arm is also a licensed site, though it requires someone else to administer it or a good mirror and steady hand. Most self-injectors rotate between thigh and abdomen. Rotation matters more than which site you choose: staying in the same spot week after week can cause lipohypertrophy, a localised thickening of tissue that slows absorption. The NHS patient information for tirzepatide covers rotation guidance in the Patient Information Leaflet, refer to that for the precise instructions that come with your pen.
One practical note: inject into subcutaneous fat, not muscle. Pinching the skin before inserting can help, especially for leaner injection sites.
How thigh and stomach compare across the factors that actually affect your weekly injection
The table below draws on the licensed SmPC and standard clinical injection guidance. No site produces different pharmacokinetics significant enough to affect outcomes at the population level, these are practical, comfort-level differences.
| Factor | Abdomen | Thigh |
|---|---|---|
| Ease of self-injection | Generally easy; large accessible area | Easy when seated; outer thigh preferred |
| Tissue availability | Usually generous subcutaneous layer | Variable; leaner thighs may need pinching |
| Absorption consistency | Good; well-studied site across GLP-1 class | Good; comparable in clinical practice |
| Injection-site reactions | Redness, bruising reported at all sites; no site is reaction-free | Bruising possible, especially outer thigh |
| Rotation space | Wide area; divide into quadrants and move each week | Generous on the outer thigh; avoid inner thigh |
| Clothing/access | Requires lifting clothing; some people prefer privacy | Accessible in most clothing with thigh exposed |
The SmPC for Mounjaro, available on the electronic Medicines Compendium (eMC), sets out the licensed injection sites and storage requirements in full. Storage is refrigerated between 2–8°C; for the exact room-temperature window if you're travelling, the leaflet is your definitive reference, we don't summarise it here because the numbers matter precisely.
What changes when you rotate between sites, and what stays exactly the same
Rotating between thigh and abdomen across weekly injections is a sound approach that many people on Mounjaro adopt naturally. It spreads any local skin response across a wider area and reduces the cumulative tissue disruption at any one spot.
What stays constant regardless of rotation: the medicine's mechanism. Mounjaro activates both GLP-1 and GIP receptors (the only dual-agonist weight-loss medicine with a UK licence) slowing gastric emptying and reducing appetite. Results from the SURMOUNT-1 trial, published in the New England Journal of Medicine, showed average body-weight reduction of around 20–21% at the 15mg dose over 72 weeks. None of that is influenced by whether the pen went into your outer thigh or your lower abdomen.
Common side effects (nausea, some digestive discomfort, occasional injection-site redness) are also site-independent in terms of their cause; they follow the medicine's action, not its entry point. If you're finding constipation or digestive discomfort a recurring issue, our guide to the best stool softeners to use alongside Mounjaro may help you find a practical option to discuss with your clinician. If you're finding a particular site consistently sore, mentioning it at your next clinical review is worthwhile, but switching sites alone won't resolve GI-related effects.
If you're comparing Mounjaro with other treatments or want to understand how the active ingredient relates to the brand name, our page on how tirzepatide and Mounjaro compare explains the relationship clearly. For people thinking about upcoming treatments in the pipeline, the retatrutide comparison is worth a read too.
Choosing a site you'll stick with every week
Consistency in technique matters more than the site itself. A clean, dry, room-temperature patch of skin; a fresh needle if you're using pen-compatible needles; a new quadrant or area from last week. That routine reduces site complications and keeps absorption steady.
The thigh works well for people who inject seated, often in the morning before getting up. The abdomen suits people who prefer to stand. Some people find the thigh easier to see and control; others find the abdomen less sensitive. There's no clinical hierarchy between the two. Try both over a few weeks and see which fits your mornings (or evenings) more naturally. It adds up over a year of weekly injections, so comfort is a reasonable deciding factor.
If you're looking at starting Mounjaro or reviewing your current treatment, and want to understand how it sits within the broader class of weight-loss medicines, our guide to how GLP-1 treatments compare to Mounjaro is a useful starting point before booking. Our Mounjaro treatment page covers eligibility, the titration schedule, and what to expect.
Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.